You are using an older browser version. Please use a supported version for the best MSN experience.

Waiving patents for Covid vaccines will not likely solve the immediate supply crunch, says CEO

Umang Vohra of Cipla says waiving intellectual property rights for Covid-19 vaccines may be able to solve the longer term problems of access to the shots, but won't address the
image beaconimage beaconimage beacon